Headache News and Research

Latest Headache News and Research

How have human organoids been used in research to study SARS-CoV-2?

In a recent review published in the journal Organoids, scientists have presented an overview on the use of human stem cell-derived organoids in understanding functionality and cellular tropism of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), a deadly beta-coronavirus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic.

7 Mar 2022

Current progress in SARS-CoV-2 vaccine candidates

In a new study, researchers illustrated the current progress and obstacles in COVID-19 vaccine development.

7 Mar 2022

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Researchers evaluated the association between cognitive impairment and clinical-functional variables in the coronavirus disease 2019 post-acute period.

7 Mar 2022

Persistence of at least one problematic symptom in the first year after traumatic brain injury

More than 70% of patients with traumatic brain injury (TBI) reported at least one problematic symptom at one year of follow-up that was new or worse than before injury.

6 Mar 2022

Breakthrough SARS-CoV-2 infection peaks at 5 months

A new study describes the incidence of breakthrough infection with SARS-CoV-2 after vaccination with one of the nucleic acid or viral vector vaccines.

28 Feb 2022

Study reveals the thalamocortical mechanism for nostalgia-induced analgesia

Ever noticed that looking at photos of good times with family or friends diminishes the pain of your headache? Nostalgia has already been shown to be helpful with pain relief, and a new study has now revealed the thalamocortical mechanism for nostalgia-induced analgesia.

28 Feb 2022

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

In a recent study, researchers evaluated the effect of COVID-19 vaccines on the symptomatic prevalence of SARS-CoV-2 infections beyond the acute phase of the disease.

28 Feb 2022

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Researchers evaluated the efficacy of SARS-CoV-2 vaccines made by Pfizer, Jansen, and Moderna against symptomatic and asymptomatic COVID-19 cases.

25 Feb 2022

Antibody levels against SARS-CoV-2 spike protein up to 12 months after COVID-19 infection in non-vaccinated individuals

A recent study assessed the persistence of SARS-CoV-2 antibody five and 12 months post-infection in non-vaccinated patients.

24 Feb 2022

Closing bars and restaurants does not appear to have suppressed COVID-19 in Japan

In a recent study posted in the Research Square* preprint server, which is under consideration at the journal Scientific Reports, a team of researchers conducted a longitudinal survey in 11 Japanese prefectures to evaluate whether early closure of full-service restaurants and bars reduced the incidence and symptoms of coronavirus disease 2019 (COVID-19) during February 2021.

23 Feb 2022

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

Researchers conducted a prospective cohort study to determine the prevalence of chemosensory dysfunction in mild to moderate COVID-19 patients in Italy.

22 Feb 2022

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

In a new study, researchers evaluated the efficacy and safety of nirmatrelvir in mild to moderate COVID-19 patients who were at high risk of severe COVID-19 disease.

18 Feb 2022

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

A recent study explored the safety, immunogenicity, and VE of the SARS-CoV-2 mRNA BNT162b2 and mRNA1273 vaccines against its Omicron VOC in HCWs in Israel.

18 Feb 2022

Study determines 115 long COVID symptoms and their associated risk factors

A new study determined which symptoms are linked with confirmed SARS-CoV-2 infection beyond 12 weeks post-infection in non-hospitalized individuals, and investigated the associated risk-factors of such symptoms.

17 Feb 2022

Risk factors for COVID-19 in older adult patients with cancer

Researchers develop a geriatric risk score to predict the risk of severe clinical outcomes in older cancer patients with COVID-19.

16 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

A new study evaluated the pregnancy outcomes of pregnant women in the third trimester who were infected by SARS-CoV-2 for the detection of the virus in the placenta and different samples of the newborn as well as detection of antibodies in the cord blood.

16 Feb 2022

Headache News and Research

Latest Headache News and Research

How have human organoids been used in research to study SARS-CoV-2?

Current progress in SARS-CoV-2 vaccine candidates

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Persistence of at least one problematic symptom in the first year after traumatic brain injury

Breakthrough SARS-CoV-2 infection peaks at 5 months

Study reveals the thalamocortical mechanism for nostalgia-induced analgesia

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Antibody levels against SARS-CoV-2 spike protein up to 12 months after COVID-19 infection in non-vaccinated individuals

Closing bars and restaurants does not appear to have suppressed COVID-19 in Japan

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

Study determines 115 long COVID symptoms and their associated risk factors

Risk factors for COVID-19 in older adult patients with cancer

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

Philippines starts vaccinating children aged five to 11 against COVID-19

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in